Grandma gives birth to her own grandchild

September 8, 2012

Cindy

Chicago, September 8: ?Setting foot in a hospital again, Emily and Mike Jordan couldn't help but feel anxious.

More than two years before, at age 29, Emily had been diagnosed with cervical cancer. But just before she was to undergo a radical hysterectomy, she was told that she was pregnant.

Faced with saving her own life or their unborn child's, the young couple made the excruciating decision to go forward with her surgery. It meant losing the baby, and forfeiting any chance at having their own children.

Or so they thought.

“I can't describe what that was like after finding out you have cancer, after finding out your chance of ever carrying a baby is gone,” Emily says, still stammering at times as she recounts that painful day in 2010.

Simply put, her body no longer had a place where a baby could grow.

But now, more than two years later, she and Mike had come from their suburban Chicago home to the labour and delivery department of a downtown hospital to realise the dream they thought was lost — to become parents, though not the way they, or most people, would have imagined.

Alongside them that day was Emily's mother, Cindy Reutzel — a fit, silver-haired 53-year-old grandmother whose profile revealed a round belly, a pregnant belly.

Reutzel was about to give birth to her own grandchild.

Just 34 years ago, Louise Brown, the first “test tube” baby, was born in Great Britain. The result? A veritable in-vitro baby boom.

It started with would-be mothers in their 20s and 30s. “Then people started pushing the envelope,” says Dr Helen Kim, director of the in vitro

fertilisation programme at the University of Chicago. “If you could help a menopausal woman in her 30s, could you help a menopausal woman in her 40s? And then it became, ‘Can you help a menopausal woman in her 50s?'

“And the answer is yes.”

Some older women were having their own babies. But more often, they were using egg donors to have their own children, or serving as surrogates or “gestational carriers”.

There was the 51-year-old grandmother in Brazil who gave birth to her twin grandchildren in 2007. There've been others, grandmothers in their 40s or 50s and even 60s.

Cindy Reutzel, Emily's mom, had a vague recollection of those stories. So when doctors shared the good news that they had been able to keep Emily's ovaries intact, Reutzel immediately made the offer.

“What if I carried your baby for you?” she asked.

Emily and Mike didn't take it too seriously at first. “We didn't really think that was a realistic option,” says Emily, who works in hospital administration.

It turned out, though, that it wasn't really that far-fetched after all, particularly for a young grandmother who's in good health, like Reutzel.

After a process that included psychological evaluation and hormonal manipulation to prepare their bodies, Kim eventually implanted Reutzel's uterus with an embryo created with an egg from Emily and Mike's sperm.

It was no easy process, with a regimen of hormonal shots. Work schedules were interrupted and vacations postponed. But Reutzel was committed.

“The thought of Emily and Mike not being able to have children and share that piece of their lives with someone just broke my heart,” says Reutzel, who lives in Chicago and is executive director at medical foundation. “I want Emily to have that connection with another human being like I had with her.”

As her belly grew, people started asking about “her baby”. But she was quick to tell them the story. This was not her baby, she was Grandma.

Admittedly, she says, she worried about the physical toll pregnancy might take, though her body handled it better than she expected. She also wondered how well she'd bounce back from a Caesarean section. That's how she had delivered Emily and her older brother, but that had been three decades ago.

Still, she reassured Emily and Mike throughout the pregnancy that the baby was fine, she was fine, everything would be fine.

Humour helped. Mike often teased his mother-in-law each time they'd take her to dinner or do something nice for her.

“Are we even yet?” he'd ask.

“Not yet,” she'd reply, laughing.

In truth, Mike and Emily knew there'd really be no way to repay this kind of gesture.

“This is a continuation of everything that she has done her entire life for me, which is to make sure that I have the best life possible,” Emily says.

All they could do, they said, was to promise to raise their baby as best they could. And that was enough for Reutzel.

“I know I gave a gift,” she says. “But I'm also getting so much in return.”

Last week, a few days after Emily's 32nd birthday, daughter sat next to mother, holding hands in the delivery room.

And Elle Cynthia Jordan was born.

“She looks just like you! She looks just like you!” Emily shouted, running from the delivery room to introduce their newborn to Mike.

Reutzel is recovering well. She even says she'd consider doing it again.

“When I watch both of them hold that baby and look into her face, it's like everything I could have imagined wanting for them — better than I could have imagined,” she says, her eyes filling with tears.

“This is what it was all about for me.”

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 25,2020

Beijing:  Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 9,2020

Jun 9: The World Health Organization says it still believes the spread of the coronavirus from people without symptoms is “rare,” despite warnings from numerous experts worldwide that such transmission is more frequent and likely explains why the pandemic has been so hard to contain.

Maria Van Kerkhove, WHO''s technical lead on COVID-19 said at a press briefing on Monday that many countries are reporting cases of spread from people who are asymptomatic, or those with no clinical symptoms.

But when questioned in more detail about these cases, Van Kerkhove said many of them turn out to have mild disease, or unusual symptoms.

Although health officials in countries including Britain, the U.S. and elsewhere have warned that COVID-19 is spreading from people without symptoms, WHO has maintained that this type of spread is not a driver of the pandemic and is probably accounts for about 6 per cent of spread, at most.

Numerous studies have suggested that the virus is spreading from people without symptoms, but many of those are either anecdotal reports or based on modeling.

Van Kerkhove said that based on data from countries, when people with no symptoms of COVID-19 are tracked over a long period to see if they spread the disease, there are very few cases of spread.

“We are constantly looking at this data and we''re trying to get more information from countries to truly answer this question,” she said. “It still appears to be rare that asymptomatic individuals actually transmit onward.”

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 19,2020

London, Jun 19: Malala Yousafzai, the youngest Nobel Peace Prize winner who once took a bullet for campaigning for girls' education in Pakistan, was over the moon on Friday after completing her degree in Philosophy, Politics and Economics at Britain's prestigious Oxford University.

Malala, 22, who attended Oxford's Lady Margaret Hall college, took to Twitter to share two pictures that show her celebrating the milestone with her family.

"Hard to express my joy and gratitude right now as I completed my Philosophy, Politics and Economics degree at Oxford," she said in the tweet, accompanied by two pictures - one showing her sitting with her family in front of a cake that says: 'Happy Graduation Malala', and the other in which she is covered with cake smiling for the camera.

In the tweet, the famed human rights activist also revealed her plans for the immediate future - Netflix, reading and sleeping.

"I don't know what's ahead. For now, it will be Netflix, reading and sleep," she wrote.

Malala was shot in the head by the Taliban militants in December 2012 for campaigning for female education in the Swat Valley in northeastern Pakistan.

Severely wounded, she was airlifted from one military hospital in Pakistan to another and later flown to the UK for treatment.

After the attack, the Taliban released a statement saying that they would target Malala again if she survived.

At the age of 17, Malala became the youngest recipient of the Nobel Peace Prize for her education advocacy in 2014 when she shared the coveted honour with India's social activist Kailash Satyarthi.

Unable to return to Pakistan after her recovery, she moved to Britain, setting up the Malala Fund and supporting local education advocacy groups with a focus on Pakistan, Nigeria, Jordan, Syria and Kenya.

The Taliban, who are against girls' education, have destroyed many schools in Pakistan.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.